Tearsheet

Buda Juice (BUDA)


Market Price (7/10/2026): $10.41 | Market Cap: $-Sector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Buda Juice (BUDA)


Market Price (7/10/2026): $10.41
Market Cap: $-
Sector: Consumer Staples
Industry: Soft Drinks & Non-alcoholic Beverages

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Trading close to highs
Dist 52W High is -4.9%, Dist 3Y High is -4.9%

Weak multi-year price returns
2Y Excs Rtn is -11%, 3Y Excs Rtn is -44%

Key risks
BUDA key risks include [1] a limited track record and scarcity of financial data as a recently public company and [2] significant execution risk tied to its ambitious plans to build new production plants and expand existing facilities.

0 Trading close to highs
Dist 52W High is -4.9%, Dist 3Y High is -4.9%
1 Weak multi-year price returns
2Y Excs Rtn is -11%, 3Y Excs Rtn is -44%
2 Key risks
BUDA key risks include [1] a limited track record and scarcity of financial data as a recently public company and [2] significant execution risk tied to its ambitious plans to build new production plants and expand existing facilities.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 7/7/2026

Buda Juice (BUDA) stock has lost about 5% since 3/31/2026 because of the following key factors:

1. Mixed fiscal Q1 2026 financial performance offset by a future growth catalyst. Buda Juice reported strong fiscal Q1 2026 results, with revenue increasing 17.7% year-over-year to $3.5 million and free cash flow surging 37% to $1.1 million, surpassing analyst expectations. However, profitability was significantly impacted by a temporary 300% spike in lime costs, which reduced the gross margin to 39.5% from 44.9% in the prior year, and led to a 50% decrease in GAAP net income to $0.4 million. Post-quarter, the announcement of an expansion into 246 Walmart stores across nine states provided a significant positive outlook, suggesting future revenue and profit growth that likely balanced the immediate concerns over profitability, preventing a sharp directional stock movement.

2. Share dilution and dividend suspension countered by strengthened liquidity. The company's outstanding share count increased from 10 million in fiscal year 2025 to 12 million by fiscal Q1 2026 due to a net common stock issuance, which raised $19.25 million in cash and provided Buda Juice with a strong cash position of $19.8 million as of March 31, 2026. While this capital infusion bolstered liquidity, the associated share dilution likely tempered per-share value appreciation. Additionally, the company halted its dividend in early fiscal 2026, which may have deterred income-focused investors and contributed to the stock remaining range-bound.

Show more
Updated on 7/7/2026

Buda Juice (BUDA) stock has lost about 5% since 3/31/2026 because of the following key factors:

1. Mixed fiscal Q1 2026 financial performance offset by a future growth catalyst. Buda Juice reported strong fiscal Q1 2026 results, with revenue increasing 17.7% year-over-year to $3.5 million and free cash flow surging 37% to $1.1 million, surpassing analyst expectations. However, profitability was significantly impacted by a temporary 300% spike in lime costs, which reduced the gross margin to 39.5% from 44.9% in the prior year, and led to a 50% decrease in GAAP net income to $0.4 million. Post-quarter, the announcement of an expansion into 246 Walmart stores across nine states provided a significant positive outlook, suggesting future revenue and profit growth that likely balanced the immediate concerns over profitability, preventing a sharp directional stock movement.

2. Share dilution and dividend suspension countered by strengthened liquidity. The company's outstanding share count increased from 10 million in fiscal year 2025 to 12 million by fiscal Q1 2026 due to a net common stock issuance, which raised $19.25 million in cash and provided Buda Juice with a strong cash position of $19.8 million as of March 31, 2026. While this capital infusion bolstered liquidity, the associated share dilution likely tempered per-share value appreciation. Additionally, the company halted its dividend in early fiscal 2026, which may have deterred income-focused investors and contributed to the stock remaining range-bound.

3. Broader industry trends presented both opportunities and challenges. The food and beverage industry in fiscal Q2 2026 experienced uneven growth, marked by increasing consumer price sensitivity and pressure on margins. While Buda Juice benefited from the "better-for-you" movement and rising consumer interest in digestive health products, aligning with its "Ultra Fresh" category, these positive trends were set against a backdrop of moderating growth in some retail segments and general cost consciousness among consumers. This mixed macroeconomic environment, combining both tailwinds and headwinds, contributed to the stock's overall stability without a pronounced upward or downward trend.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

3/31/2026 to 7/9/2026
ReturnCorrelation
BUDA-3.0% 
Market (SPY)15.6%-9.0%
Sector (XLP)1.5%-10.7%

Fundamental Drivers

null
null

Market Drivers

12/31/2025 to 7/9/2026
ReturnCorrelation
BUDA  
Market (SPY)10.5%-2.6%
Sector (XLP)7.7%2.1%

Fundamental Drivers

null
null

Market Drivers

6/30/2025 to 7/9/2026
ReturnCorrelation
BUDA  
Market (SPY)22.7%-2.6%
Sector (XLP)4.9%2.1%

Fundamental Drivers

null
null

Market Drivers

6/30/2023 to 7/9/2026
ReturnCorrelation
BUDA  
Market (SPY)75.6%-2.6%
Sector (XLP)20.9%2.1%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
BUDA Return-----31%31%
Peers Return5%14%26%15%19%8%123%
S&P 500 Return27%-19%24%23%16%9%99%

Monthly Win Rates [3]
BUDA Win Rate-----43% 
Peers Win Rate39%56%61%53%56%58% 
S&P 500 Win Rate75%42%67%75%67%43% 

Max Drawdowns [4]
BUDA Max Drawdown------ 
Peers Max Drawdown-13%-25%-21%-19%-20%-17% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: KO, COCO, BUDA, SUJA, PEP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/9/2026 (YTD)

How Low Can It Go

BUDA has limited trading history. Below is the Consumer Staples sector ETF (XLP) in its place.

EventXLPS&P 500
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-12.2%-9.5%
  % Gain to Breakeven13.8%10.5%
  Time to Breakeven146 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-12.1%-24.5%
  % Gain to Breakeven13.8%32.4%
  Time to Breakeven46 days427 days
2020 COVID-19 Crash
  % Loss-24.2%-33.7%
  % Gain to Breakeven31.9%50.9%
  Time to Breakeven140 days140 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-10.7%-17.9%
  % Gain to Breakeven12.0%21.8%
  Time to Breakeven78 days123 days
2008-2009 Global Financial Crisis
  % Loss-31.8%-53.4%
  % Gain to Breakeven46.7%114.4%
  Time to Breakeven371 days1085 days

Compare to KO, COCO, BUDA, SUJA, PEP

In The Past

State Street Consumer Staples Select Sector SPDR ETF's stock fell -5.9% during the 2025 US Tariff Shock. Such a loss loss requires a 6.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

BUDA has limited trading history. Below is the Consumer Staples sector ETF (XLP) in its place.

EventXLPS&P 500
2020 COVID-19 Crash
  % Loss-24.2%-33.7%
  % Gain to Breakeven31.9%50.9%
  Time to Breakeven140 days140 days
2008-2009 Global Financial Crisis
  % Loss-31.8%-53.4%
  % Gain to Breakeven46.7%114.4%
  Time to Breakeven371 days1085 days

Compare to KO, COCO, BUDA, SUJA, PEP

In The Past

State Street Consumer Staples Select Sector SPDR ETF's stock fell -5.9% during the 2025 US Tariff Shock. Such a loss loss requires a 6.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Buda Juice (BUDA)

Buda Juice (BUDA) is a pioneering company in the UltraFresh™ juice category, specializing in delivering always cold, freshly crafted juices, lemonades, and wellness shots to grocery retailers, primarily in Texas with plans for broader U.S. expansion. The company's core innovation is its end-to-end cold chain platform, which maintains continuous 35°F temperature control from fruit to shelf. This system enables retailers to offer truly fresh and safe products with an extended 8-12 day shelf life without requiring their own infrastructure investment or operational complexity, effectively solving the industry's challenge of scaling UltraFresh™ quality.

The company's product portfolio is diverse and leverages its proprietary cold chain process. It includes premium organic Buda Juice wellness shots, a value-forward non-organic Buda Fresh line offering various citrus juices (lemon, lime, orange, grapefruit) and citrus-based lemonades/limeades, and robust private label manufacturing capabilities for both organic and non-organic fresh citrus products. By strategically focusing on citrus as its foundational ingredient, Buda Juice ensures product development flexibility and speed-to-market advantages across its offerings.

Buda Juice serves grocery retailers who wish to provide high-quality, fresh beverages to their customers, bridging the gap between shelf-stable options and labor-intensive in-store juicing. The company targets multiple market segments, from premium organic consumers with its wellness shots to a broader market with its conventional fresh citrus juices, lemonades, and private label offerings. Buda Juice has demonstrated strong financial growth, with revenue increasing from $5.6 million in 2022 to $11.2 million in 2024, and is executing a disciplined geographic expansion strategy with planned facilities in South Carolina (2026) and Arizona/Nevada (2027).

AI Analysis | Feedback

Here are 1-2 brief analogies for Buda Juice:

  • The Chobani of UltraFresh™ juice, enabled by a proprietary cold chain for grocery stores.
  • Beyond Meat for fresh juice: creating a new, UltraFresh™ category of beverages for grocery retailers.

AI Analysis | Feedback

```html
  • Buda Juice (Organic): Premium organic wellness shots available in multipack glass bottles.
  • Buda Fresh: A value-forward line of non-organic fresh citrus juices, lemonades, and limeades.
  • Private Label Products: Custom-branded fresh citrus juices, lemonades, and limeades produced for other retailers.
```

AI Analysis | Feedback

Buda Juice (BUDA) primarily sells its products to other companies, specifically grocery retailers. The provided background information states that Buda Juice "delivers always cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas." While the company serves "multiple brand lines and retail customers," specific names of these grocery retailer customers are not disclosed in the provided text.

AI Analysis | Feedback

null

AI Analysis | Feedback

Horatio Lonsdale-Hands, Co-Founder, Chairman & Chief Executive Officer
Horatio Lonsdale-Hands co-founded Buda Juice in 2014, bringing a unique approach to health and juicing. Prior to Buda Juice, he co-founded Advance Global Communications (AGC) in 2001, where he served as President and grew it into one of the largest international carriers, dominating the Mexican traffic market for 12 years. In 1989, he co-founded and served as Chairman and CEO of ZuZu, Inc., transforming it into a major player in the restaurant industry with over 100 locations and pioneering the "Fast Casual" concept in Mexican food. Earlier in his career, he co-founded Nipper's Champagne Clubs in 1982 and worked as a Deal Maker at Bear Stearns & Drexel Burnham Lambert.

Clint Lee Bowers, Chief Financial Officer
Clint Lee Bowers serves as the Chief Financial Officer of Buda Juice. No further specific background information regarding previous company management, sales, or private equity involvement is publicly available from the provided search results.

Bryan Clements Herr, Executive Chairman
Bryan Clements Herr serves as the Executive Chairman of the Board. As Executive Chairman, he has previously founded, scaled, and successfully exited companies in the "fresh" category, achieving distribution in leading national chains.

Bernard Lucien Nussbaumer, Co-Founder & Director
Bernard Lucien Nussbaumer co-founded Buda Juice in 2013. He also serves as a Director for the company. He is described as an avid yogi, photographer, and film producer.

Karen Dale Lonsdale-Hands, Vice President of Marketing
Karen Dale Lonsdale-Hands holds the position of Vice President of Marketing at Buda Juice, Inc. She reported an initial beneficial ownership of restricted common stock in February 2026.

AI Analysis | Feedback

Here are the key risks to Buda Juice's business:

Key Risks to Buda Juice

  1. Reliance on Maintaining a Continuous Cold Chain and Managing Short Shelf Life: Buda Juice's entire "UltraFresh™" business model is predicated on an end-to-end cold chain platform that maintains continuous 35°F temperature control and delivers products with a relatively short 8-12 day shelf life. Any disruption, failure, or inefficiency in this cold chain across production, storage, or distribution could lead to product spoilage, significant waste, potential food safety issues, costly recalls, and severe damage to the company's reputation and brand integrity. The inherent short shelf life also necessitates highly efficient inventory management and rapid distribution to minimize losses.
  2. Dependence on Citrus Supply and Price Volatility: The company explicitly states that citrus is its "foundational ingredient" for its product portfolio, including juices, lemonades, and private label offerings. This heavy reliance exposes Buda Juice to substantial risks related to the availability, quality, and pricing of citrus fruits. Factors such as adverse weather conditions, crop diseases (e.g., citrus greening), pests, or geopolitical events in key growing regions could lead to supply shortages or significant price increases, directly impacting production costs, margins, and the ability to meet customer demand.
  3. Execution Risk of Geographic Expansion: Buda Juice is pursuing an aggressive geographic expansion strategy, with plans to establish new facilities in South Carolina by 2026 and Arizona/Nevada by 2027. While this expansion is aimed at serving a larger percentage of the U.S. population, it introduces considerable execution risks. These include the challenges associated with significant capital expenditure, constructing and commissioning new operational facilities, establishing new distribution networks, scaling production while maintaining quality standards, navigating new regulatory environments, and successfully penetrating new competitive markets. Failure to execute these expansions efficiently and effectively could strain financial resources, dilute focus, and negatively impact profitability and growth targets.

AI Analysis | Feedback

The emerging threat to Buda Juice is the potential widespread adoption by grocery retailers of advanced, automated, and low-maintenance in-store juicing machines. Buda Juice’s core value proposition is bridging the gap between shelf-stable products and operationally challenging in-store juicing by delivering UltraFresh™ juice with an 8-12 day shelf life, enabling retailers to offer fresh juice without infrastructure investment or operational complexity. Should new technologies mature that allow retailers to easily install automated systems capable of producing truly on-demand, minutes-old fresh juice directly in their stores with minimal labor and operational overhead, it would directly undercut Buda Juice’s offering. Such a development would provide a superior level of freshness and potentially customization directly to the consumer, making Buda Juice’s delivered 8-12 day "UltraFresh™" product comparatively less appealing and potentially rendering their specialized cold chain platform redundant for retailers aiming for the absolute freshest option.

AI Analysis | Feedback

The addressable markets for Buda Juice's main products and services in the U.S. are substantial, encompassing fresh/cold-pressed juices, lemonades, and wellness shots.

Fresh and Cold-Pressed Juice Market

The U.S. cold-pressed juice market was estimated at USD 248.3 million in 2025 and is projected to reach USD 422.8 million by 2032, demonstrating a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. Another estimate places the U.S. cold-pressed juices market size to increase by USD 185.1 million at a CAGR of 6.8% between 2024 and 2029. The North America cold-pressed juices market was valued at USD 310.05 million in 2025. The broader North America fruit juice market, which includes fresh and cold-pressed options, was valued at USD 43.98 billion in 2025 and is predicted to grow to USD 64.30 billion by 2034, with a CAGR of 4.31% from 2026 to 2034. Additionally, the 100% juice market in North America held over 36.97% of the global market revenue share, with the global 100% juice market estimated at USD 29.99 billion in 2023 and projected to reach USD 50.49 billion by 2030.

Lemonade Market

The U.S. lemonade market size was estimated at USD 1610.0 million (USD 1.61 billion) in 2024. This market is projected to grow to USD 3148.0 million (USD 3.148 billion) by 2035, exhibiting a CAGR of 6.2% during the forecast period from 2025 to 2035. North America accounted for approximately 33.8% of the global lemonade market share in 2024.

Wellness Shots Market

The U.S. functional shots market, which includes wellness shots, was estimated at USD 243.0 million in 2024. It is projected to reach USD 855.7 million by 2033, growing at a CAGR of 15.2% from 2025 to 2033. North America is a dominant region in the wellness shots market, holding approximately 38.5% of the global market share in 2024, translating to a market value of around USD 624.7 million. Another report indicates North America holding a 35.0% market share of the global functional shots market in 2024, which was valued at USD 645.31 million.

AI Analysis | Feedback

Expected Drivers of Future Revenue Growth for Buda Juice (BUDA)

Buda Juice (BUDA) is poised for future revenue growth over the next 2-3 years, driven by several strategic initiatives:

  1. Geographic Expansion: The company plans significant expansion beyond its current Texas operations, with new facilities scheduled for South Carolina in 2026 and Arizona/Nevada in 2027. This expansion will enable Buda Juice to serve a larger percentage of the U.S. population and access new retail markets.
  2. Expansion of Retailer Partnerships: Buda Juice's end-to-end cold chain platform allows grocery retailers to offer UltraFresh™ juice without significant infrastructure investment or operational complexity. This value proposition is expected to drive growth in the number of retail customers partnering with Buda Juice across existing and new markets.
  3. Increased Sales Volume from Existing Product Portfolio: The company's diverse product portfolio, including Buda Juice (Organic) wellness shots, Buda Fresh – Value-Forward Offering (Non-Organic) citrus juices and lemonades, is expected to see increased sales volume. This growth will come from deeper penetration within existing retail partners and the onboarding of new customers.
  4. Growth in Private Label Offerings: Buda Juice explicitly leverages its private label manufacturing capabilities to achieve broader market access and volume scale. Expanding its private label product lines and securing new private label partnerships will be a significant contributor to future revenue.

AI Analysis | Feedback

Capital Expenditures

  • The company is executing a disciplined geographic expansion strategy with planned facilities in South Carolina (2026) and Arizona/Nevada (2027).

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

BUDAKOCOCOSUJAPEPMedian
NameBuda Jui.Coca-ColaVita CocoSuja LifePepsiCo  
Mkt Price10.1882.6371.2510.18137.8671.25
Mkt Cap-355.54.1-188.3188.3
Rev LTM-49,284659-96,90449,284
Op Inc LTM-15,56597-14,49514,495
FCF LTM-12,56265-9,2829,282
FCF 3Y Avg-7,21865-7,7937,218
CFO LTM-14,63173-13,45613,456
CFO 3Y Avg-9,22468-12,7949,224

Growth & Margins

BUDAKOCOCOSUJAPEPMedian
NameBuda Jui.Coca-ColaVita CocoSuja LifePepsiCo  
Rev Chg LTM-5.1%23.1%-5.6%5.6%
Rev Chg 3Y Avg-4.3%14.5%-2.5%4.3%
Rev Chg Q-12.1%37.3%-6.4%12.1%
QoQ Delta Rev Chg LTM-2.8%8.0%-1.5%2.8%
Op Inc Chg LTM-10.6%30.6%-17.0%17.0%
Op Inc Chg 3Y Avg-8.9%127.4%-6.9%8.9%
Op Mgn LTM-31.6%14.7%-15.0%15.0%
Op Mgn 3Y Avg-30.2%14.1%-14.3%14.3%
QoQ Delta Op Mgn LTM-0.5%1.2%-0.2%0.5%
CFO/Rev LTM-29.7%11.0%-13.9%13.9%
CFO/Rev 3Y Avg-19.3%12.3%-13.7%13.7%
FCF/Rev LTM-25.5%9.8%-9.6%9.8%
FCF/Rev 3Y Avg-15.1%11.8%-8.3%11.8%

Valuation

BUDAKOCOCOSUJAPEPMedian
NameBuda Jui.Coca-ColaVita CocoSuja LifePepsiCo  
Mkt Cap-355.54.1-188.3188.3
P/S-7.26.2-1.96.2
P/Op Inc-22.842.0-13.022.8
P/EBIT-19.542.0-13.219.5
P/E-25.949.1-18.025.9
P/CFO-24.356.1-14.024.3
Total Yield-6.9%2.0%-9.7%6.9%
Dividend Yield-3.1%0.0%-4.1%3.1%
FCF Yield 3Y Avg-2.4%3.7%-4.0%3.7%
D/E-0.10.0-0.30.1
Net D/E-0.1-0.0-0.20.1

Returns

BUDAKOCOCOSUJAPEPMedian
NameBuda Jui.Coca-ColaVita CocoSuja LifePepsiCo  
1M Rtn29.9%2.2%-4.0%-34.5%-3.4%-3.4%
3M Rtn1.0%6.4%45.9%-43.0%-11.5%1.0%
6M Rtn25.5%20.7%29.1%-43.0%0.8%20.7%
12M Rtn25.5%22.3%93.8%-43.0%6.6%22.3%
3Y Rtn25.5%52.2%180.2%-43.0%-16.9%25.5%
1M Excs Rtn17.9%2.7%-4.8%-32.3%-3.9%-3.9%
3M Excs Rtn-11.9%-3.6%33.7%-54.2%-21.2%-11.9%
6M Excs Rtn16.9%14.8%28.4%-51.6%-7.5%14.8%
12M Excs Rtn4.4%-0.2%68.5%-64.1%-15.0%-0.2%
3Y Excs Rtn-43.8%-20.3%98.0%-112.3%-86.8%-43.8%

Comparison Analyses

null

Segment Financials

Revenue by Segment
$ Mil20242023
Branded - Non-Organic64
Private Label/Other43
Branded - Organic22
Total119


Price Behavior

null
BUDA Betas & Captures as of 6/30/2026

 1M2M3M6M1Y3Y
Beta0.910.070.040.100.120.01
Up Beta-1.01-2.30-0.45-0.730.89-0.68
Down Beta0.721.181.67-2.54-1.34-2.47
Up Capture137%-8%-32%-5%-2%-0%
Bmk +ve Days11244067140429
Stock +ve Days112029505050
Down Capture162%78%13%-26%-17%-9%
Bmk -ve Days10172358112321
Stock -ve Days101830616161

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BUDA
BUDA25.6%74.0%0.92-
Sector ETF (XLP)4.4%13.4%0.072.1%
Equity (SPY)22.3%12.5%1.33-2.6%
Gold (GLD)24.4%27.8%0.775.5%
Commodities (DBC)23.6%18.7%1.004.0%
Real Estate (VNQ)13.2%13.9%0.65-8.4%
Bitcoin (BTCUSD)-42.8%42.8%-1.1812.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BUDA
BUDA4.7%74.0%0.92-
Sector ETF (XLP)6.2%13.4%0.242.1%
Equity (SPY)13.4%17.1%0.61-2.6%
Gold (GLD)18.0%18.3%0.805.5%
Commodities (DBC)7.5%19.5%0.284.0%
Real Estate (VNQ)2.9%18.9%0.06-8.4%
Bitcoin (BTCUSD)12.3%53.5%0.4212.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with BUDA
BUDA2.3%74.0%0.92-
Sector ETF (XLP)7.3%14.8%0.362.1%
Equity (SPY)15.8%17.9%0.75-2.6%
Gold (GLD)11.7%16.1%0.595.5%
Commodities (DBC)6.1%18.0%0.274.0%
Real Estate (VNQ)5.2%20.7%0.22-8.4%
Bitcoin (BTCUSD)58.0%66.2%0.9812.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date6152026
Short Interest: Shares Quantity0.0 Mil
Short Interest: % Change Since 5312026-12.6%
Average Daily Volume0.0 Mil
Days-to-Cover Short Interest1.4 days

Earnings Returns History

Updated 6/3/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
SUMMARY STATS   
# Positive000
# Negative000
Median Positive   
Median Negative   
Max Positive   
Max Negative   
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
SUMMARY STATS   
# Positive000
# Negative000
Median Positive   
Median Negative   
Max Positive   
Max Negative   

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/26/202610-K
09/30/202501/08/2026424B4
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/26/202610-K
09/30/202501/08/2026424B4
Core Cache Last Updated: 7/9/2026